Shree Ganesh Remedies Ltd — Important, 14-05-2026: Company Update

Shree Ganesh Remedies Limited presented its Q4 and full-year financial results. FY26 focused on consolidation, structurally strengthening the business for future growth. Q4 revenue from operations stood at 33.20 Cr, a 36% increase year-on-year, with Q4 PAT at 6.27 Cr. For the full year, revenue was 109.29 Cr, and PAT reached 17.77 Cr. The company made strong progress on CRAMS engagements in agrochemicals, pharmaceuticals, and electronics, completing pilot trials and anticipating commercial production soon, marking a key inflection point. Block 7 expansion remains on track for Q2FY27 commissioning, supporting niche molecules. Despite a challenging operating environment, the company is poised for growth with new facilities and a stronger product development pipeline.